Welcome, everyone, to our Q3 2020 Financial Results Earnings Presentation. On this call, we have our President and CEO, Mikael Bratt and our Chief Financial Officer, Fredrik Vistien and myself, Anders Trapp, VP, Investor Relations. During today's earnings call, our CEO will provide a brief overview of our Q3 results as well as provide an update on our general business and market conditions. After Michael, Fredrik will provide further details and commentary around the financials. At the end of our presentation, we will remain available to respond to your questions.
And as usual, the slides are available through a link on the homepage of our corporate website. Turning to the next slide. We have the Safe Harbor statement, which is an integrated part of this presentation and includes the Q and A that follows. During the presentation, we will reference some non U. S.
GAAP measures. The reconciliations of historical U. S. GAAP to non U. S.
GAAP measures are disclosed in our quarterly press release and the 10 Q that will be filed with the SEC. Lastly, I should mention that this call is intended to conclude at 3 p. M. CET, so please follow a limit of 2 questions per person. I will now hand it over to our CEO, Mikael Bratt.
Thank you, Anders. Looking now into the Q3 2020 highlights on the next slide. Before we start with the formal presentation, I would like to acknowledge our employees for their hard work and commitment to health and safety, cost control, quality and delivery precision in these challenging times. The COVID-nineteen pandemic is 1st and foremost a human crisis, where safeguarding health and safety is our first priority. I am very pleased that our operations reported higher sales, higher profit margins and higher cash flow compared to last year, despite challenging market conditions.
The strong performance was a result of faster than expected light vehicle production recovery and the forceful actions we initiated earlier in 2020 to manage the effects of the pandemic on our operations. The LVP recovery is in the quarter started slow and volatile, but grew gradually stronger and more stable, supported by incentives, pent up demand and inventory restocking post lockdown. We continued to execute on our strong order book and our sales increased despite global LVP falling by over 4%. To manage the evolving situation, we have accelerated cost savings, reduced expenses and strengthened our balance sheet. This includes personnel and material cost reductions and executing efficiency programs.
I am confident that the actions implemented and planned are positioning Autoliv well regardless of how the market will develop. It is encouraging that we can report the strongest operating cash flow in our history for the Q3 and that we were able to reduce CapEx by close to 40% compared to a year earlier. This enables delivering towards our target to a leverage ratio in the range of 0.5 times to 1.5 times. The order intake in the 1st 9 months of the year supports a prolonged period for outgrowth. However, customer sourcing activities was, as expected, low in the quarter with more than half our planned sourcing for the year expected in the Q4.
We see the positive sales trend continuing in the 1st weeks of Q4. However, economic uncertainty, risk for further lockdowns and the risk of increasing unemployment and its impact on the consumer demand may temper the outlook for the Q4 light vehicle production. Looking now on the financial highlights on the next slide. Our consolidated net sales increased 0.5% compared to Q3 2019, despite the global light vehicle production falling by more than 4%. Adjusted operating income, including cost for capacity alignments, antitrust related matters and in 2019, separation of our business segments increased by 13% to US206 $1,000,000 mainly as a result of our forceful cost reduction activities.
The adjusted operating margin increased by 110 basis points to 10.1%, which is the 2nd highest margin for the Q3 in the past 10 years. Operating cash flow of US352 $1,000,000 and free cash flow of US276 $1,000,000 were significantly above the Q3 2019 levels and the highest cash flow on record for the 3rd quarter. Looking now on sales development on the next slide. I am pleased that our sales outperformed organically the global light vehicle production by almost 5%, with outperformance in all major regions. We had a solid sales development in China, growing organically by more than 10%, outperforming light vehicle production by close to 2 percentage points.
Sales in North America increased organically by around 2%, which was more than 2 percentage points better than the light vehicle production. Our outperformance was mainly coming from positive vehicle mix and recent launches with several customers such as Tesla, VW and Toyota. In Europe, the trend from previous quarters continued as our sales outperformed light vehicle production by 3 percentage points, impacted by recent launches at PSA and Toyota. In Japan, the light vehicle production mix was negative with production of smaller vehicles for the domestic market being less affected by the pandemic than larger export vehicles. Despite this, our sales decreased organically in line with the light vehicle production decline.
In Rest of Asia, organic sales increased by 5%, which was 22 percentage points better than the light vehicle production decline. Within the region, sales in South Korea showed a strong increase. In the quarter, slowing sales of replacement inflators had a 0.6 percentage points negative effect on sales, mainly affecting North America, China and Japan. Looking on the next slide. We have several high volume, high content model launches during the quarter.
We did not experience any major delays of launches, and we expect the high number of launches to continue into the Q4. The models shown on this slide have an autolip content per vehicle between $120,000,000 $330,000 2 of the vehicles are pure EVs and many of the remaining models will be available with some sort of electrified powertrain. The long term trend to higher CPV is supported by the continued trend of more center and knee airbags. For example, Nissan Rogue and Ford Mustang Mach E will have dual knee airbags from Autoliv. Now I will hand over to our Chief Financial Officer, Fredrik Vistien, who will talk about the financials on the next slide.
Thank you, Mikael. This slide highlights our key figures for the Q3. Our net sales were $2,000,000,000 a 0.5% increase compared to the same quarter last year. Gross profit increased by $21,000,000 and the gross margin increased by 90 basis points compared to the same quarter 2019. The higher gross margin was primarily driven by labor and direct material productivity despite direct COVID-nineteen related costs and operational inefficiencies.
The adjusted operating income increased by $23,000,000 to $206,000,000 mainly due to the higher gross profit. Reported earnings per share was 1.12 dollars and our adjusted return on capital employed and return on equity were 22% 25%, respectively. The operating cash flow improved by 150 $7,000,000 to $352,000,000 for the Q3 2020. We did not pay a dividend in the quarter. Looking now on the adjusted operating margin bridge on the next slide.
Our adjusted operating margin of 10.1 percent was 110 basis points higher than in the Q3 2019. As illustrated by the chart, the adjusted operating margin was positively impacted by lower cost for raw materials of 40 basis points and lower combined cost for SG and A and RD and E of 20 basis points. SG and A declined by $6,000,000 or 6% compared to the prior year, mainly due to lower costs for personnel. RD and E net costs increased by $3,000,000 compared to the prior year as reduced personnel cost was more than offset by negative effects from lower engineering income. FX effect impacted the operating margin negatively by 60 basis points.
This is caused by transactional effects from a number of 10 basis points. This was a result of strict cost discipline put in place during the first half of the year and the effects from our structural efficiency programs, partly offset by the negative impact of COVID-nineteen related costs and inefficiencies. Additional support came from governance governments in connection with furloughing, short term work weeks and similar activities totaling approximately $10,000,000 Looking on the next slide, we have the EPS development. The reported earnings per share improved by 0 point 14
dollars from higher adjusted operating income and 0 point
0 $6 from favorable impact on tax, which was partially offset by $0.04 from higher capacity alignment and $0.05 from financial items. In Q3 2020, the adjusted earnings per share increased by 18% $0.18 to $1.48 compared to the same period 1 year ago. Looking now to our cash flow on the next slide. For the Q3 of 2020, operating cash flow was $352,000,000 an increase of 1 $7,000,000 compared to last year. The increase in operating cash flow was a result of the higher net income and improved working capital.
Our strict inventory control, close collaboration with suppliers, reduced over dues and improved payables, together with positive effects from other noncash items, were the main drivers for the improvement. Capital expenditures amounted to SEK 7 $76,000,000 in the 3rd quarter, which is about 3.8% in relation to sales. Compared to last year, CapEx decreased by 38% as we suspended or delayed investments substantially. Our free cash flow was $276,000,000 an increase of $203,000,000 year over year. As a consequence of the sharp reduction in CapEx, our last 12 months depreciation and amortization was in line with CapEx.
A more normalized market will lead to some increase in investments again, But our ambition is, however, to reduce the gap between CapEx and D and A over time. The last 12 months cash conversion was more than 200% as a result of both the low CapEx level, positive contribution from changes in working capital and noncash items. Over the last 12 months, operating cash flow was almost $700,000,000 with a free cash flow of almost $350,000,000 Now looking on the next slide. We have, as you know, a long history of a prudent financial policy. In the current volatile market conditions, our balance sheet focus remains unchanged.
The leverage ratio decreased from 2.9 at the end of last quarter to 2.4x as of September 30. The improved leverage was a result of our net debt decreasing by 2 $65,000,000 in the quarter, while EBITDA over the last 12 months at the same time increased by 29,000,000 dollars It is worth noting that our net debt is the lowest since the spin off of Veoneer in 2018. Our ambition is to improve our net debt and EBITDA in the near future. However, as the leverage ratio is calculated on the last 12 months data, we expect the ratio to remain elevated for some time. On the next slide, you can see that our liquidity position remains strong.
We had around $2,000,000,000 in liquidity and unused credit facilities on September 30. The revolving credit facility was fully repaid on October 2, 2020, and is available as needed. We have no need for any major refinancing of existing debt until 20 22. Therefore, we believe that we have secured a significant liquidity cushion to manage our business successfully in the current challenging We have seen the expected positive effects of the programs. We estimate the savings from our 2 structural efficiency programs in the quarter to be around 15 The programs are mainly impacting Americas and Europe.
And when the 2 programs are fully implemented, we expect headcount to have been reduced by more than 1700 employees. The cost for structural efficiency program 2 is estimated to be around $65,000,000 and cash out to be spread from this quarter until the Q4 of 2021. In addition to the structural efficiency programs, we made a further provision of around $30,000,000 in the Q3 for footprint optimization in Europe, including a plant closure involving more than 200 employees in Germany. In Germany. Production is expected to end mid-twenty 23 subject to negotiations with the local works council.
We continue to evaluate further footprint optimizations. Looking on the next slide. We are closely monitoring the development of the COVID-nineteen pandemic and gauging its continuing impact on the automotive industry. The outlook for major light vehicle markets is still difficult to predict due to economic uncertainty and the risk of further lockdowns. These factors may have major effects on light vehicle production in the 4th quarter.
The expectations on light vehicle production in North America have continuously improved and Q4 is now expected to show only a modest contraction supported by stronger U. S. Light vehicle sales expectations and continued need to restock depleted inventories. In Europe, the low inventory level induced by the lockdowns is expected to support production into the 4th quarter. Despite this, IHS assumes European production to fall around 1% in the 4th quarter due to a decline in Eastern Europe.
In China, light vehicle sales have shown a year over year growth over the past 6 months and inventories are balanced. IHS expects some demand stagnation in the 4th quarter with light vehicle production dropping 5% as the year over year comparisons get more next On the next slide, we have the impact on our business in the Q4. As we have communicated earlier this year, we see both tailwinds and headwinds for 2020. Related to the Q4 of 2020, you can see the main tailwinds include growth from executing on the strong order book and the structural efficiency programs. Programs.
The main headwinds include operational headwinds from COVID-nineteen, declining and unpredictable light vehicle production as well as lower inflator replacement sales. We believe the tailwinds and headwinds for the Q4 are of similar magnitudes and should lead to an adjusted operating margin for the full year 2020 of around 6%. However, economic uncertainty, risks for further lockdowns and the potential increase in unemployment and its effect on consumer demand may still impact this Q4 outlook. I will now hand back to Mikaela.
Thank you, Fredrik. Moving on to the next page. We have summarized our full year 2020 indications. These indications exclude cost for capacity alignment and antitrust related matters. Backed by recent product launches, we expect a further pickup of sales outperformance compared to light vehicle production in the 4th quarter, supporting a full year outperformance of around 6 percentage points.
We expect a 13% organic sales decline. Our net sales decline is assumed to be around 14.5%, including negative currency translation effects of around 1.5%. We expect an adjusted operating margin of around 6%. Operating cash flow is expected to be below the 2019 level of USD 844,000,000 It is important to note that the outlook assumes that the current relative business stability prevails. Turning the page.
To summarize, the Q3 outcome reflects our efforts to come out of this crisis as a stronger company. We see the positive sales momentum continuing into the 1st weeks of Q4. However, it is important to realize that this crisis is not behind us. There are still potential risks for further lockdowns affecting business stability and visibility. I am proud that we have a solid organization that can manage a strict cash and cost control, while continuing to execute on our long term strategy with the health and safety of our employees as the first priority.
I will now hand back to Anders.
Thank you, Mikael. Turning the page. We conclude our formal comments for today's earnings call, and we would like to open up the line for questions. So I hand it back to you, Nadia.
Thank you. Ladies and gentlemen, we now begin the question and answer And the first question comes from the line of Ampos Engilao from Handelsbanken. Please ask a question.
Thank you very much. Two questions for me. First, just a housekeeping question on engineering income, if we should expect any other situation on this seasonal pattern that we have seen on Q4 with engineering income being slightly higher? That's my first question. Second question is more on the operating leverage.
If I remember correctly, I think Autoliv had 1.4% EBIT margin in 2,009, and then it went up to 12% in 2010. And we see a similar pattern here on the operating leverage. What kind of a pushback should we think about 2021 in terms of operating leverage, I mean, provided that the IHS outlook of a 13% growth for LVPs sticks and you had some outperformance on that? Those are my 2 questions. Thank you.
No, I think on the first question there on the engineering side, I mean, we have no changes to the seasonality in engineering income as such. But it doesn't mean that it needs to be the same year over year here, of course. But seasonality wise, it is the same, and that is to be expected also this year. When it comes to the operating leverage, as you know, we have talked about that in the previous quarters here, and we have guided in terms of a rule of thumb there on a growth scenario with around 20% and when you have these sharp declines more in the magnitude of 30% and also, of course, when you have big rebounds in the same way, also you should be in the 30s. And sequentially, I think that's what you have seen here and actually a little bit stronger than that.
When it comes to 2021, I think we wait with any comments around 20 21 until we get into the time for making a call on the next year. I would say with the current circumstances, you further out your look, it's more difficult it becomes. So I think right now, we are focusing then on the end of this year and the full 2020 outlook here as we have reinstated the guidance for the remaining months here.
Fair enough.
Thank you.
Thank you. And your next question
Yes, thank you very much. So your reinstated guidance implies a very strong revenue outgrowth exit rate in 2020. And to be fair, you've always said that in the Q4 that some of these launches were back end loaded and they will be strong, but this seems potentially better than close to double digit or even better. Any sort of fundamental read through in here? Are you seeing general acceleration or have things just shaped out from a timing point of view, just more concentrated in the Q4 than initially thought?
No. I would say generally not. I think it followed the base assumptions that we went into this year with that our full year outperformance around 6%, and that's what we're reconfirming here. We have also said from the beginning here that it would be back end loaded in the year. And we have not really seen any delays in launches either despite this very volatile time.
So of course, there is 1, so 2 here and there that slides a little bit. But I would say that's also happening in a normal year. So nothing exceptional there. So bottom line is that it's following the regional outlook for the year and meeting down to around 6% outperformance.
Okay, great. And then second question around your order intake. So you said, I guess, it was as expected, a little bit on the softer side in the 3rd quarter. The Q4 would be more than half of the year. If I remember well, in the first half, you had said that it was flat year over year in dollar terms despite of seeing meaningful decline in production.
So putting it all together, it feels like your order intake for the year could be up quite a bit on a full year basis versus 2019. Is that correct? Is that consistent with your initial expectation? And what does that mean for your midterm growth profile?
Yes. We haven't given any specific guidance on order intake for the year. I think the work assumptions that we have said is that the market share that we are growing into is what we intend to defend in the outer years here. Then in terms of new order intake, specifically in quarters and specific years may fluctuate a little bit, of course, as they always do because it's not a straight line in terms of activities from the OEM side. And I would say as far as we have communicated this year, we will come back to the exact win rate when we close 2020 here.
But what we have indicated here is that in terms of activities, we are still backfilling our order book, so we can continue to outperform the market here in the years to come.
Great. Thank you.
Thank you. And your next question comes from the line of James Picariello from KeyBanc Capital. Please ask your question.
Hey, guys. Question on 2021. So what are some of the offsets for next year related to possible lapping COVID related costs, like the unwind of this year's temporary austerity measures. Just how should we think about what that company what the company's base incremental margin range is, the structural cost savings layered on top of that? And then are there any cost offsets that come to mind?
Is there anything you can share with us to get to that bridge? Thanks.
I think a little bit too early to make a bridge to 2021 here based on what I said earlier here around the uncertainty in the market to start with, but also that it's not until the beginning of next year we will give guidance on where we think we will end up in 2021. But what I can say here is that, I mean, our focus here is, of course, to manage through this crisis as effectively as possible. And I think the whole organization here has shown the strength in terms of street cost control, managing the liquidity and of course, with that also making sure that we carry as much as possible into the sustainable part here, of course. But when we also move further into the recovery here, the immediate harsh stops, I would say, when it comes to cost control and so on, of course, will readily fade out. But with that said, we also have a very strong focus inside the company every day here to make the company leaner and more effective as we forward.
And also on the strategic side, the roadmaps we laid out in the Capital Markets Day last year leading up to our ambitions here in the outer years is still ongoing. So it's all hands on deck to deliver on those. Then of course, under these circumstances, we need to find, in some cases, new ways of working around that. But there is a full agenda around that. So as long as we see end market or light vehicle production here that holds up, we believe that 2021 should be a good stepping stone towards our midterm targets.
Got it. Is there any quantification around the German plant closure, the savings and the timing related to that move?
No. It's just what we see what we presented here is that the result we took is around €30,000,000,000 and it relates to 200 employees roughly and that the production will end in around 2023. But that's as much as we would like to share on that.
Because as you know, we have footprint review as a part of the strategic road maps, And we are not communicating a big package here. We communicate when we have decisions and when we move forward on it. So what we communicated now in connection with the Q3 was one of those decisions. And if and when we have more, we will come back to that. But it's an area for our long term strategy here.
Got it. Thanks, guys.
Thank you. And the next question comes from the line of Brian Johnson from Barclays. Please ask your question.
Yes. Two questions. 1 kind of keeping probing at the issue of cost takeout and second more strategic. On the cost takeout, if you look year over year $30,000,000 improvement in operating income, just I know you're not giving 2021 guidance, but if we kind of think about the base of fixed versus variable costs that that implies, how much of that actually comes back because it's a temporary measure?
We haven't broken it down. And I think it's in large, I would say, of course, the majority of it will come back as we get into more normalized situation when you look at the total number. I mean, we flexed out very, very hard the workforce here when we had to basically come to a halt in April here. Now when we coming back here and the volumes are increasing again. And as we also taking market share here, we need to backfill that and get that people back.
So it has been a challenging quarter in that regard when we had had such big fluctuations. But when you get into more stable situation, the majority will for sure come back here. But I would say right now, for sure, in Q3, we have not been able to run the whole operation effectively either. So at the same time, we have strict cost control and strict control over our cash here. There is, of course, an efficiency in the whole volume swings here and also the extra measurements for the corona COVID-nineteen situation as well.
So it's difficult to give you a COVID breakdown on that. And I think I have to refer to my answer earlier here that it's all hands on deck to drive towards our midterm target.
Correct. I
mean, the second question.
You've seen that we have an effect of about SEK 15,000,000 from the structural efficiency program. So that's broken out. And then also broken out Okay.
So that's bankable.
And the cost structure, I think you can assume that it's fairly close to a normal
Q3.
Okay. And second question, you did flag the 2 bev key launches as well as EV variants. Is there anything in the seat belt airbag world that's materially different between an electric vehicle and a similar sized ICE vehicle in terms of your CPV and or your competitive position?
No, I would say that increasing electrical vehicles is neutral to positive for us. At the starting point, it's same type of products. Then, of course, weight and noise becomes increasingly important in electrical vehicles that tend to be more silent and more quiet inside the vehicle. And so that is very, very important. Then we have also additional products going in like the power safety switch, which is a feature where you cut the battery source battery source in the event of a crash.
So that's additional product coming into electric EVs. So neutral to positive for us.
And in terms of your competitive position, you have 2 or 3 very strong competitors. Are they showing up at the EV bids as well? And is there any difference in your win rate on EVs versus the broader the traditional product lines?
I mean, they are, of course, also into electrical vehicles. So as it is, as a stocking point, the same type of products. And I would say that relative our market position, we are also well represented in the EVIS in relation to that, in relation to our position.
Okay. Thank you.
Thank you.
Thank you. And your next question comes from the line of Joseph Spak from RBC Capital Markets. Please ask your question.
Thank you, everyone. I want to get back to some of the performance this quarter because I know you mentioned between SEP 12, I think it was a $15,000,000 year over year benefit. But your direct workforce, I believe, actually increased year over year on similar sales levels. So it would seem to suggest there's some efficiencies there as well. And I was wondering if you could provide any sort of additional color as to sort of what else sort of drove some of the improved performance in the quarter.
Yes. I think it's basically a list or what we tried to describe also in the bridge, that we have a favorable impact on, say, productivity on the material side to an order extent and then to some extent also on the personnel side, but it's more on the production overhead than direct labor. There, we still have inefficiencies due to the COVID-nineteen restrictions we have in the operations. And then the other component is, of course, that we still are benefiting from lower discretionary spending, which has continued from the Q2 into the Q3, which should also carry forward to some extent also into the next quarter, but with a to a lesser extent.
Okay. And the second question is there's been some news about a competitor potentially facing a seat belt recall. Is that a potential opportunity for you to help out the industry like with the inflator situation?
I mean seat belt is, of course, a big part of our portfolio, and we are always there to support our customers. But in relation to this, I have no specific comments or insight into that. And I think it's early days there as well.
Okay. Thank you very much.
Thank you. And your next question comes from the line of Roald Lache from Wolfe Research. Please ask your question.
Thank you. A few things. One is just typically the Q4 exit rate of revenue outperformance says something about subsequent year just as your backlog for the new model year kicks in. And, of course, next year regional mix could be pretty good if Europe and North America accelerate more than China. Are there any offsets or things that we should be keeping in mind?
I know that you're not providing guidance for next year, but just at a high level, anything that you would want to mention as a potential offsetting headwind?
No, I think no, I have nothing specific to comment. As I said, I mean, we don't go into the details for 2021. I think it's early days also. But I mean, I think we have in last year laid out what we believe is our expected average growth rates going forward here and outperformance. So I think that's still standing there.
Of course, with the regional swings that you have seen in this year and where that normalizes, you mathematically get a reverse effect of that also. So on top of that, I would say there is nothing additional to the equation.
Okay. And then, the savings on Slide 13, I just was hoping you can clarify program 1 and program 2 was $10,000,000 and $5,000,000 in Q3. And then for 2021, you expect $10,000,000 plus 25 $1,000,000 step up from the program 2 and plus maybe some benefit from incremental footprint reductions. Am I reading that correctly? And maybe you could just also just reference that the original plan where you laid out 300 basis points of margin improvement to get to 12%, about 100 basis points of that was structural savings.
To what extent are these any of these incremental to what you had originally contemplated?
No. I think the baseline is in terms of what we see as opportunities going forward is the communication we had last year then everything we do here now is, of course, a part of the overall journey and just managing through the ordinary course of business here and driving efficiency and productivity across the board. So in relation to our if I understand your question right here, in terms of our regional journey here, it is not incremental to debt, if that was what you're asking. So it's a part of it, of course.
Okay. And just lastly, just a minor issue. It looks like mathematically, you're expecting Q4 EBIT to increase by something like $26,000,000 and on a revenue increase of something like $186,000,000 And just looks like even just factoring in the FX changes, it's less than the 30% normal incremental. Is this just the unusual cadence of Q4 true ups and recoveries or anything like that, that would be
per se. And of course, the full year guidance that we are giving is to the best of our knowledge as we have indicated here. I mean, we have, of course, cloud on the skies here in terms of the COVID-nineteen, but I would describe it that it's on the sky in the sky, but it's not raining yet. So we have to wait and see if we will have any impact. But with everything we know now, this is the best we can predict.
Okay. All right.
Thank you.
Nothing other than that.
Thank you. Your next question comes from the line of Ryan Brinkman from JPMorgan. Please ask your question.
Hi, great. Thanks for taking my question. Just given the faster pace of recovery in the industry here, your reduction in net debt, do you have any updated thoughts here on capital allocation? I did hear you say that you aim to improve both EBITDA and net debt in the near future. Are there any particular milestones, whether in terms of your own net debt or leverage or macro I would say
I would say that there is no specific triggering point here. I think it's like we have always said here that our ambition here is to have a pragmatic view on how to and when to return to more normal dividend situation here. I think it's still too early. The uncertainty is still very high as a result of the COVID-nineteen, and it's a question for later date. But it is a question about where are we in terms of stability in the industry and what we think about our own performance going forward from that point on.
So we have to come back to that when we have come through this immediate COVID-nineteen crisis here. But as where we are right now, it's too early.
Okay. Thanks. And then I realize there have been several questions sort of around this, but looking at that 110 basis point improvement attributed to operations on the margin bridge, It'd be great if you just sort of speak to what you think kind of the underlying sustainable progress is there. Let's say that there's a vaccine between now and 3Q 'twenty one, such that you no longer have these inefficiencies and direct costs stemming from COVID. You retain some portion of your savings and you cycle past some of the austerity measures.
What do you think would be wise to model now if you thought the virus is going away by the Q3 of next year in terms of operations going forward?
I think I will I mean, it's a lot of ifs and bucks in that question there and becomes very hypothetical answer if I would get into any details there. So plus that we are not talking about 2021 yet. So I would like to reiterate what I said before here about if we have a stable reasonable market, a healthy market for 2021, we should see that as a stepping stone towards our midterm targets. But more than that, I think it's difficult to say at this point in time when the uncertainty is so high. Okay.
I see. Thank you very much.
Thank you. And your next question comes from the line of Erik Golrang from SEB. Please ask your question.
Thank you. Two questions from my side. If I read it correctly, your overall volumes were slightly down in the 3rd quarter, yet organic growth was positive. So is that a mix factor? Or has there been any kind of change on the pricing development?
Then the second question and returning to a topic discussed, but could you just help us out what the big swing is Q3 into Q4? Clearly, higher organic growth expected in the 4th quarter, yet a much muted year on year margin development. What's happening between Q3 and Q4 for you to give that outlook?
Maybe Frederic, you can take the second question there. Yes. I thought we'd have.
Okay. So the can you repeat the second question again, please?
Yes, sure. So just I mean, we've talked about it, but you indicate a flat more flattish margin development in Q4 year on year in spite of still a higher organic growth than what we saw in Q3. So what's the big delta that shifts the development to such a big extent from Q3 into Q4?
I'm sorry, I'm not sure I understand your question. Can you answer it in a different way?
Well, there's a okay, a bit different. Do you have a slide there where you indicate the balance between negative and positive factors on margins for Q4? And I guess also the full year margin outlook implies a much more muted year on year development for the margins in spite of organic growth. So what's the what moves between Q3 and Q4 in terms of holding back the margin development year
year? Okay. Yes. So I mean, we will run into a more assuming that the volumes now come as we are predicting them with the outlook, we will come into a more normalized operating level. And with that, the savings we have currently from, say, a lower discretionary spend, our assumption is that they will, let's say, be reduced and also going into the Q4.
So you will have a smaller benefit from that in the Q4 than what you had in the Q3. Then also, we've had a net positive from if you look at the cost incurred relative to COVID-nineteen and the benefit or subsidies we received, that was also a net benefit also because of timing of how we recovered some of these subsidies. So those are 2 elements that will go away. And then it's yes, if we can also look at the productivity in the plants, we are still operating, as we said, at not optimum and efficient levels. So those, I think, are the main components that you the factory and if you then look at the leverage for the Q4.
Okay. Thanks.
Thank you.
And then on the first question on pricing, on why organic growth is better than volumes?
It's mix effect coming through there. So there's no change to the pricing.
Okay. Thank you.
Thank you. And your next question comes from the line of Sascha Gomes from Jefferies. Please ask your question.
Yes. Good afternoon. Thanks for taking my questions. The first one would actually be on your margin again. I think historically, you said that in phases with very high number of ramp ups, you tend to have a bit of a margin dilution.
Now we see that you have a lot of ramp ups for a lot of high volume models. Should we think that as a quality sign for your order book that you have a very healthy order book with very high profitability and that like the historic comparison doesn't really fit here?
No. I think as always, it's a lot of work to trim the system when you have a ramp up. I think when you look at this quarter, it's so many things going on at the same time here. And I would say this has also been a quarter where you have had not so many launches as we have had before. As we said, that also is geared toward the later part of the year.
So we see that coming through more in the Q4 than in Q3. But there is no changes to the, I would say, the normal effect where you have lower performance of the programs in the ramp up phase than you have when it's mature. So there's no changes to that. Do we have a healthier order book? And as I said, it also hangs together more question about how is the mix coming through in terms of product and different platforms coming through.
So that is nothing I think you should read into in this short term analysis of Q3.
I see. And then my second question, the reduction in inventories, is that a reflection that your OEM customers are less volatile in their behavior? And you think you can run a bit like more efficient ship? Is that the right interpretation?
Well, definitely, it is a much more stable environment now coming out of the Q3 than we had at the beginning of the quarter. Yes, so there is we have a much better ability to operate at more efficient inventory levels at the end of the quarter than we had at the beginning of the quarter. I think you can see that both if you look at the inventory turnover rate versus the previous quarter but also year over year, there's improvement. So yes, that has significantly improved over the last couple of months.
And you think that there's further room? Or is that the level where you think you can hold it relatively speaking, obviously?
I think for the moment, think we believe this is a healthy level. We still have suppliers that are distressed, and it's not gone away yet, say, the issues that we have in the supply chain. So for the time being, we think that this is a healthy inventory level that we operate on considering the risk in the entire supply chain.
Appreciate it. Thank you very much.
Thank you. And your last question comes from the line of Victoria Greer from Morgan Stanley. Please ask your question.
Afternoon, can you hear me okay?
We hear you. Hi there.
Great. Just two questions, please. Firstly, thinking about CapEx for 2021, should we think about any delayed spending that you might need to come back to there? Probably, if you could, in thinking about that in absolute terms, would be helpful given that there's a bit of volatility, obviously, around sales expectations. And the second one, are you seeing any disruption as the restrictions increase again for COVID, particularly in Europe?
I think you said that actually things are okay right now, but do you see anything coming down the track there that we should bear in mind? Thanks.
Thank you. Let me maybe take the last question first, and then I hand over to Frederic to comment on the CapEx. I mean, as you say, I mean, we see some restrictions coming into play here in Europe. But so far, nothing is impacting what we can see in our supply chain here or in our customers. So far so good, but we remain very active and on the Delaware tier to take any measurements or actions necessary if that would come into play.
And I mean, we have maintained our task force here to review, for example, on an almost daily basis here, our supplier base and the freight lines here. So we are well prepared to take that on, but so far so good.
On the CapEx side, I mean, we have now, as you see in the Q3, a higher investment level than the 2nd quarter, and you should expect that also to continue into the Q4. I mean our ambition is to, over time, get the CapEx to sales ratio to below 5%. But specifically for 2021, I think we will come back to that specific guidance when the time is right for that.
So probably not to think about below 5% for 2021 at this point?
I think we will give that guidance when the time is right.
Great. Thank you.
Thank you. And you can please continue. We're not taking any more questions.
Thank you very much, Nadia. So let me just say that before we end today's call, I would like to say that we are operating from a a position of strength in terms of liquidity, flexibility and dedicated employees. And we will continue to improve efficiency, optimize our footprint and and 24 targets. Our 4th quarter earnings call is scheduled to Tuesday, January 26, 2021. And thank you, everyone, for participating in today's call.
We sincerely appreciate your continued interest in Autoliv. And until next time, stay safe.